期刊文献+

成纤维细胞活化蛋白在上皮癌中表达的意义及研究进展 被引量:1

原文传递
导出
摘要 成纤维细胞活化蛋白(fibroblast activation protein,FAP)广泛存在于上皮癌组织中,在肿瘤间质成纤维细胞选择性表达而在正常的成熟组织中几乎不表达,是上皮癌的特异性靶标。FAP具有蛋白酶活性,并且可与其他细胞表面蛋白分子形成复合物,可能作用于细胞信号传导,参与肿瘤间质重塑和血管网的形成,调节肿瘤细胞的生长、分化、黏附和转移。目前,有许多临床前期实验及临床研究报导,靶向FAP能有效抑制上皮癌的生长和转移。FAP将可能成为治疗上皮癌的新靶点。现综述总结了FAP的生物学特性,其表达对上皮癌发生发展的影响,以及靶向FAP的抗肿瘤研究进展。
作者 蔡凡 彭枫
出处 《华西医学》 CAS 2011年第8期1268-1271,共4页 West China Medical Journal
  • 相关文献

参考文献35

  • 1C. Kloft,E-U. Graefe,P. Tanswell,A. M. Scott,R. Hofheinz,A. Amelsberg,M. O. Karlsson.Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients[J]. Investigational New Drugs . 2004 (1)
  • 2Tlsty TD,,Coussens LM.Tumor stroma and regulation ofcancer development. Annu Rev Pathol . 2006
  • 3Hayward SW.Preclinical assessment of fibroblast activationprotein as a target for antitumor therapy. Future Oncol . 2010
  • 4Kraman M,Bambrough PJ,Arnold JN,et al.Suppression ofAntitumor Immunity by Stromal Cells Expressing FibroblastActivation Protein-α. Science . 2010
  • 5Hofheinz RD,al-Batran SE,Hartmann F,et al.Stromalantigen targeting by a humanized monoclonal antibody:an earlyphaseⅡtrial of sibrotuzumab in patients with metastaticcolorectal cancer. Onkologie . 2003
  • 6Liao D,Luo Y,Markowitz D,et al.Cancer associatedfibroblasts promote tumor growth and metastasis by modulatingthe tumor immune microenvironment in a 4T1 murine breastcancer model. PLoS One . 2009
  • 7Loeffler M,Krüger JA,Niethammer AG,et al.Targetingtumor-associated fibroblasts improves cancer chemotherapy byincreasing intratumoral drug uptake. The Journal of Clinical Investigation . 2006
  • 8Wen Y,Wang CT,Ma TT,et al.Immunotherapy targetingfibroblast activation protein inhibits tumor growth and increasessurvival in a murine colon cancer model. Cancer Science . 2010
  • 9Narra K,Mullins SR,Lee HO,et al.PhaseⅡtrial of singleagent Val-boroPro(Talabostat)inhibiting Fibroblast ActivationProtein in patients with metastatic colorectal cancer. Cancer Biotherapy . 2007
  • 10Eager RM,Cunningham CC,Senzer NN,et al.PhaseⅡassessment of talabostat and cisplatin in second-line stageⅣmelanoma. BMC Cancer . 2009

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部